Thomas E. Lad
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Bone health and treatments
- Cancer survivorship and care
- Cancer Diagnosis and Treatment
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 36
- Bone health and treatments 13
- Lung Cancer Research Studies 7
- Cancer survivorship and care 7
- Peptidase Inhibition and Analysis 5
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 8
- Medical Imaging and Pathology Studies 5
- Co-authors
- Lynn L. Anderson (1 shared paper)Subhash C. Kukreja (10 shared papers)Steven Piantadosi (2 shared papers)David F Cella (3 shared papers)Giuseppe Giaccone (1 shared paper)Paul S. Thomas (1 shared paper)David K. Payne (1 shared paper)JOHN C. RUCKDESCHEL (1 shared paper)
- Journals
- Investigational New Drugs (9 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)Cancer (5 papers)Calcified Tissue International (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesUnited KingdomPhilippines
In The Last Decade
Thomas E. Lad
71 papers receiving 2.4k citations
Thomas E. Lad's Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 681
- Otorhinolaryngology 64
- Obstetrics and Gynecology 96
- Orthopedics and Sports Medicine 78
Countries citing papers authored by Thomas E. Lad
This map shows the geographic impact of Thomas E. Lad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Lad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Lad more than expected).
Fields of papers citing papers by Thomas E. Lad
This network shows the impact of papers produced by Thomas E. Lad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Lad. The network helps show where Thomas E. Lad may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Lad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 356 | |
| 2 | 2015 | 284 | |
| 3 | 1994 | 259 | |
| 4 | 2012 | 155 | |
| 5 | 1982 | 140 | |
| 6 | Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial Hit paper breakdown → | 2023 | 127 |
| 7 | 1988 | 84 | |
| 8 | 1980 | 82 | |
| 9 | 2013 | 74 | |
| 10 | 2018 | 62 | |
| 11 | 2018 | 58 | |
| 12 | 1988 | 56 | |
| 13 | 1982 | 49 | |
| 14 | Measuring quality of life in culturally diverse populations. | 1996 | 45 |
| 15 | 2014 | 45 | |
| 16 | 1984 | 42 | |
| 17 | Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group. | 1991 | 41 |
| 18 | Acute vascular episodes associated with therapy for carcinomas of the upper aerodigestive tract with bleomycin, vincristine, and cisplatin. | 1982 | 34 |
| 19 | 2024 | 34 | |
| 20 | 1994 | 34 |
About Thomas E. Lad
Thomas E. Lad is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Cancer Research and Hematology, having authored 75 papers that have together received 2.5k indexed citations. Recurring topics across this work include Bone health and treatments (13 papers), Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (7 papers), Cancer survivorship and care (7 papers), Esophageal Cancer Research and Treatment (5 papers), Medical Imaging and Pathology Studies (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (681 citations), Otorhinolaryngology (64 citations), Obstetrics and Gynecology (96 citations) and Orthopedics and Sports Medicine (78 citations). Thomas E. Lad has collaborated with scholars based in United States, United Kingdom and Philippines. Frequent co-authors include Lynn L. Anderson, Subhash C. Kukreja, Steven Piantadosi, David F Cella, Giuseppe Giaccone, Paul S. Thomas, David K. Payne, JOHN C. RUCKDESCHEL, Sofia F. Garcia and Jin‐Shei Lai. Their work appears in journals such as Investigational New Drugs, International Journal of Radiation Oncology*Biology*Physics, Cancer, Calcified Tissue International and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.